US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist

3.280
-0.030-0.91%

Close Mar 21 16:00 ET

3.280
0.0000.00%

Post 19:02 ET

621.53MMarket Cap-7.63P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.984M	--
--	2024/Q4	-- / 2.208M	--
Nov 6, 2024	2024/Q3	1.855M / 2.573M	--
Aug 1, 2024	2024/Q2	2.390M / 2.415M	--
May 2, 2024	2024/Q1	2.108M / 3.682M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.984M--

--2024/Q4-- / 2.208M--

Nov 6, 20242024/Q31.855M / 2.573M--

Aug 1, 20242024/Q22.390M / 2.415M--

May 2, 20242024/Q12.108M / 3.682M--

Unlock Free Earnings Estimates

Open Account

Arbutus Biopharma Earnings Reports

Arbutus Biopharma | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:10 ET

Arbutus Biopharma | 8-K: Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 6, 2024 07:37 ET

Arbutus Biopharma | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 16:53 ET

Arbutus Biopharma | 8-K: Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 1, 2024 07:36 ET